IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Mankind Pharma IPO listing price is ₹ 1424.05, issue price is [●], and currently trading at ₹ 2439.20 as on May 22, 2025. Mankind Pharma IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Mankind Pharma IPO is a Book Building listing on BSE,NSE exchange. The company is based in New Delhi and caters to Pharmaceutical sector. Axis Capital , Iifl Securities , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Mankind Pharma IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Mankind Pharma IPO offer price is ₹ 1080.00 and got listed at ₹ 1424.05. Read Mankind Pharma IPO details mentioned above.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 1
Issue
Price :
[●]
Listing Price :
₹ 1424.05
Previous Day Closing
₹ 2531.40
Mankind Pharma IPO, based in New Delhi, operates in the Pharmaceutical sector with a focus on pharmaceutical products with a major focus on domestic markets. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Mankind Pharma IPO size is ₹ 4326.36 Cr. Crores with fresh issue size of Rs 4326.36 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Mankind Pharma IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Mankind Pharma IPO allotment status on the registrars website, Kfin Technologies Limited. Mankind Pharma IPO refund dates are [●].
Mankind Pharma IPO is expected to be listed on 9th May 2023.
The upper price band for the Mankind Pharma IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Mankind Pharma IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Mankind Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Mankind Pharma IPO is finalised.
The merchant banker for Mankind Pharma IPO is Axis Capital Limited , Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited . Axis Capital Limited , Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Mankind Pharma IPO RHP for further details.
The registrar for Mankind Pharma IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Mankind Pharma IPO through their official website or helpline.
Mankind Pharma IPO was subscribed 15.32 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Mankind Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Mankind Pharma Financial Review Page
Merchant Banker(s) of Mankind Pharma IPO: Axis Capital Limited , Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Mankind Pharma IPO subscription was 15.32 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Mankind Pharma IPO listed at a listing price of 1424.05 against the offer price of 1080.00.
The current market price of Mankind Pharma is 2439.20.
Why Us?
